A Study of the Effect of Tocilizumab on Markers of Atherogenic Risk in Patients With Moderate to Severe Rheumatoid Arthritis
Clinical trial NCT00535782 · COMPLETED
Trial details
- NCT number
- NCT00535782
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-31
- Primary completion
- 2008-09-30
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.